NIVISCO: Study of the efficacy and safety of treatment with NIVolumab in Immuno-Stimulation in hospitalized obese adult subjects at risk of severe development of COVID-19. Multicenter randomized controlled trial in two parallel groups.
- Funded by Ministre des Solidarités et de la Santé (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Ministre des Solidarités et de la Santé (France)Principal Investigator
Emmanuel DisseResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Clinical trials for disease managementSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified